Meibo (Perfluorohexyloctane): A Patient’s Guide to Treating Dry Eye Disease
Schedule your eye exam today!
Why Is Treating Meibomian Gland Dysfunction (MGD) Important?
Meibomian Gland Dysfunction (MGD) is a leading cause of Dry Eye Disease, affecting a majority of patients. The Meibomian glands in your eyelids produce oils that create the top layer of your tear film, preventing it from drying out. In MGD, these oils become thick and unhealthy, leading to rapid tear evaporation and common dry eye symptoms.
Symptoms of MGD include eye dryness, burning, grittiness, redness, and fluctuating vision.
By directly addressing tear evaporation and improving gland function, Meibo helps relieve these symptoms at their source.
Benefits of Meibo Treatment
Meibo offers several benefits as a treatment for dry eye, particularly for those with Meibomian Gland Dysfunction, due to its unique mechanism of action and formulation.
It is the first and only FDA-approved eye drop that directly targets tear evaporation.
It provides sustained symptom relief by protecting the tear film and supporting healthier gland function.
The formula is preservative-free, which minimizes irritation and is ideal for patients requiring frequent drops.
It is proven to be safe and effective in clinical studies for mild to severe cases of MGD-related dry eye.
What to Expect During Treatment
Understanding the typical timeline for improvement can help manage expectations and encourage consistent use of Meibo eye drops.
Clinical studies and patient reports show that many people begin to feel relief from dryness and irritation within two weeks.
Significant improvements in both signs and symptoms are often seen after eight weeks of consistent use as Meibo helps restore a healthier eye surface and tear film.
Are There Any Side Effects?
While Meibo is generally well-tolerated, it is important to be aware of potential side effects and when to seek medical advice.
Meibo is generally very well tolerated. The most common side effect is mild and temporary eye irritation or blurred vision upon applying the drops.
If you experience any severe discomfort, pain, or signs of an allergic reaction, stop using the product and contact our doctor immediately.
Frequently Asked Questions
Here are answers to some common questions about Meibo and its use in managing dry eye disease.
Meibo is a prescription eye drop containing perfluorohexyloctane, a water-free and preservative-free liquid specially designed to reduce tear evaporation by forming a protective film over the tear film. It also helps dissolve thickened oils in the Meibomian glands, improving tear quality and reducing symptoms of dry eye caused by Meibomian Gland Dysfunction (MGD).
MGD is a leading cause of evaporative dry eye, caused by blocked or thickened oil secretions in the eyelid glands. Treating MGD improves the oil layer of the tear film, reduces tear evaporation, and alleviates dryness, burning, irritation, and fluctuating vision common in dry eye patients.
Traditional MGD treatments include warm compresses, eyelid hygiene, antibiotics, and anti-inflammatory medications, which help remove gland blockages and reduce inflammation. Meibo differs by directly creating a lasting barrier to prevent tear evaporation and improving gland oil quality without preservatives, which enhances comfort and reduces irritation during frequent use.
Use one drop in each affected eye, typically four times daily or as prescribed by our eye doctor. Remove contact lenses before use and wait at least 30 minutes before reinserting them. Meibo can be used alongside other treatments such as warm compresses and eyelid hygiene for optimal benefit.
Many patients report relief from dryness and irritation within 2 to 4 weeks of consistent use. Full symptom improvement and healthier tear film stabilization generally occur after about 8 weeks of regular treatment.
Meibo is typically well tolerated. Some users may experience mild, temporary eye irritation or blurred vision immediately after application. Severe discomfort or signs of allergic reaction are rare but require discontinuation of the drops and consultation with a doctor.
Yes, Meibo has been shown to be safe and effective for long-term management of dry eye caused by MGD. Its preservative-free formula makes it suitable for frequent use without causing additional irritation.
Meibo is specifically indicated for dry eye patients whose condition is related to Meibomian Gland Dysfunction and evaporation issues. Patients with other dry eye causes should consult their eye doctor for appropriate treatment options.
Yes, Meibo can be effectively combined with standard therapies such as warm compresses, eyelid hygiene routines, artificial tears, and other prescribed medications to improve overall dry eye symptom relief and gland function.
Store Meibo in a cool, dry place away from direct sunlight. Always wash your hands before applying to prevent contamination. Follow any additional storage or usage instructions provided by your healthcare provider or pharmacist.
Taking Care of Your Eye Health with Alden Leifer, MD and Associates
If you have dry, irritated eyes due to MGD, the experienced team at Alden Leifer, MD and Associates in Paterson, Hawthorne, Teaneck, Passaic, Clifton, Fair Lawn, Garfield Passaic county, Bergen county, and Essex county can help. We use advanced diagnostics to confirm your condition and develop a personalized treatment plan, which may include perfluorohexyloctane (Meibo) drops. Our approach combines education, practical tips, and compassionate care to help you “See great till 98”, and beyond!